COVID-19 vaccines spread hope as Cigna helps spread the word

The U.S. Food and Drug Administration (FDA) authorized the first COVID‑19 vaccines with more just weeks away. Cigna welcomes the roll-out of safe and effective COVID-19 vaccines, and has trust in the review and approval processes.

“Together, industry and government have responded to this crisis with unprecedented speed, while also safeguarding public health and safety. I’m often asked these vaccines should be trusted. And my answer is ‘Yes.’ I personally participated in one of the clinical trials, understand the FDA’s thorough evaluation process, and appreciate the public openness of drugs companies and the FDA,” said Cigna Chief Clinical Officer, Dr. Steve Miller, during a six-minute video available to view now on Cigna.com.

Vaccines offer hope that this pandemic will someday end. Until then, prevention is key – washing hands, wearing masks, physical distancing, per the  guidance provided by local health authorities nationwide, the U.S. Centers for Disease Control and Prevention, and the World Health Organization. Cigna also maintains a 24-hour telephone help line, 866.912.1687, to allow employees and family members to speak with qualified clinicians about how to cope with anxiety, stress, or other issues related to the impact of COVID-19.

Learn more

Content is for informational purposes only, based on current information, and subject to change. Please follow official guidance provided by local health authorities and government officials when developing reopening plans to meet the unique needs and characteristics of each location and workforce population.

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.

All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2021 Cigna. All rights reserved